AbbVie Inc. Files 8-K Report

TL;DR

ABBV filed an 8-K on Feb 26, 2025 - likely routine updates.

AI Summary

On February 26, 2025, AbbVie Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial transactions or material events were detailed in the provided excerpt, suggesting it may be a routine filing or related to exhibit updates.

Why It Matters

This filing indicates AbbVie Inc. is providing updates to the SEC, which could include new exhibits or other required disclosures relevant to investors monitoring the company's regulatory compliance.

Risk Assessment

Risk Level: low — The filing appears to be a standard 8-K for "Other Events" and exhibits, without immediate indication of significant new risks or material adverse information.

Key Players & Entities

• AbbVie Inc. (company) — Filer
• February 26, 2025 (date) — Date of earliest event reported

FAQ

From the Filing

0001104659-25-017490.txt : 20250226 0001104659-25-017490.hdr.sgml : 20250226 20250226170439 ACCESSION NUMBER: 0001104659-25-017490 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250226 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250226 DATE AS OF CHANGE: 20250226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 25671203 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 8-K 1 tm255723d7_8k.htm FORM 8-K false 0001551152 Common Stock, $0.01 Par Value ABBV 0001551152 2025-02-26 2025-02-26 0001551152 us-gaap:CommonStockMember exch:XNYS 2025-02-26 2025-02-26 0001551152 exch:XCHI us-gaap:CommonStockMember 2025-02-26 2025-02-26 0001551152 abbv:SeniorNotes0.750Percentdue2027Member exch:XNYS 2025-02-26 2025-02-26 0001551152 abbv:SeniorNotes2.125Percentdue2028Member exch:XNYS 2025-02-26 2025-02-26 0001551152 abbv:SeniorNotes2.625Percentdue2028Member exch:XNYS 2025-02-26 2025-02-26 0001551152 abbv:SeniorNotes2.125Percentdue2029Member exch:XNYS 2025-02-26 2025-02-26 0001551152 abbv:SeniorNotes1.250Percentdue2031Member exch:XNYS 2025-02-26 2025-02-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025       ABBVIE INC. (Exact name of registrant as specified in its charter)       Delaware   001-35565   32-0375147 (State of Incorporation)   (Commission File Number)   (IRS Employer Identification Number)     1 North Waukegan Road North Chicago , Illinois 60064-6400 (Address of principal executive offices, including zip code)    ( 847 ) 932-7900   ( Registrant’s telephone number, including area code )       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.01 Par Value   ABBV   New York Stock Exchange Chicago Stock Exchange 0.750% Senior Notes due 2027   ABBV27   New York Stock Exchange 2.125% Senio